A longitudinal observational study of brain atrophy rate reflecting four decades of multiple sclerosis: A comparison of serial 1D, 2D, and volumetric measurements from MRI images

Neuroradiology

Volumn 52, Issue 2, 2010, Pages 109-117

  Martola, Juha ^a   Bergström, Jakob ^a   Fredrikson, Sten ^a   Stawiarz, Leszek ^a   Hillert, Jan ^a   Zhang, Yi ^a   Flodmark, Olof ^b   Lilja, Anders ^b   Ekbom, Anders ^a   Aspelin, Peter ^a   Wiberg, Maria Kristoffersen ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brain atrophy; Disability; MRI; Multiple sclerosis

Indexed keywords

INTERFERON;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; BRAIN TISSUE; BRAIN VENTRICLE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; IMAGE PROCESSING; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; VOLUMETRY;

ADULT; AGED; AGING; ATROPHY; BRAIN; CEREBRAL VENTRICLES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ORGAN SIZE; TIME FACTORS; YOUNG ADULT;

EID: 77949264232     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-009-0593-9     Document Type: Article

References (32)

1. RA Bermel R Bakshi 2006 The measurement and clinical relevance of brain atrophy in multiple sclerosis Lancet Neurol 5 158 170 10.1016/S1474-4422(06) 70349-0 16426992 (Pubitemid 43107851)
2. F Barkhof 2002 The clinico-radiological paradox in multiple sclerosis revisited Curr Opin Neurol 15 239 245 10.1097/00019052-200206000-00003 12045719 (Pubitemid 34596884)
3. PA Brex R Jenkins NC Fox WR Crum JI O'Riordan GT Plant DH Miller 2000 Detection of ventricular enlargement in patients at earliest clinical stage of MS Neurology 54 1689 1691 1:STN:280:DC%2BD3c3islyrsA%3D%3D 10762518
4. TL Luks DE Goodkin SJ Nelson S Majumdar P Bacchetti D Portnoy R Sloan 2000 A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis Mult Scler 6 332 1:STN:280:DC%2BD3crhtF2lug%3D%3D 11064443
5. E Fisher RA Rudick JH Simon G Cutter M Baier JC Lee D Miller B Weinstock-Guttman MK Mass DS Dougherty NA Simonian 2002 Eight-year follow-up study of brain atrophy in patients with MS Neurology 59 1412 1420 1:STN:280:DC%2BD38nnt1WktA%3D%3D 12427893
6. D Horakova MG Dwyer E Havrdova JL Cox O Dolezal N Bergsland B Rimes Z Seidl M Vaneckova R Zivadinov 2009 Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study J Neurol Sci 282 112 119 10.1016/j.jns.2008.12.005 19168190
7. NC Fox R Jenkins SM Leary VL Stevenson NA Losseff WR Crum RJ Harvey MN Rossor DH Miller AJ Thompson 2000 Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI Neurology 54 807 812 1:STN:280: DC%2BD3c7lt1yhtA%3D%3D 10690967
8. NF Kalkers N Ameziane JC Bot A Minneboo CH Polman F Barkhof 2002 Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype Arch Neurol 59 1572 1576 10.1001/archneur.59.10.1572 12374494
9. RA Bermel J Sharma CW Tjoa SR Puli R Bakshi 2003 A semiautomated measure of whole-brain atrophy in multiple sclerosis J Neurol Sci 208 57 65 10.1016/S0022-510X(02)00425-2 12639726 (Pubitemid 36294155)
10. DT Chard CM Griffin GJ Parker R Kapoor AJ Thompson DH Miller 2002 Brain atrophy in clinically early relapsing-remitting multiple sclerosis Brain 125 327 337 10.1093/brain/awf025 1:STN:280:DC%2BD387hsVeksw%3D%3D 11844733
11. N De Stefano PM Matthews M Filippi F Agosta M De Luca ML Bartolozzi L Guidi A Ghezzi E Montanari A Cifelli A Federico SM Smith 2003 Evidence of early cortical atrophy in MS: relevance to white matter changes and disability Neurology 60 1157 1162 12682324
12. X Lin LD Blumhardt CS Constantinescu 2003 The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: a three-dimensional study Acta Neurol Scand 108 401 406 10.1034/j.1600-0404.2003. 00160.x 1:STN:280:DC%2BD3srjs1agtA%3D%3D 14616292 (Pubitemid 37464119)
13. B Turner N Ramli LD Blumhardt T Jaspan 2001 Ventricular enlargement in multiple sclerosis: a comparison of three-dimensional and linear MRI estimates Neuroradiology 43 608 614 10.1007/s002340000457 1:STN:280:DC%2BD3Mvps1OmtQ%3D%3D 11548165 (Pubitemid 32755680)
14. VL Stevenson DH Miller SM Leary M Rovaris F Barkhof B Brochet V Dousset M Filippi R Hintzen X Montalban CH Polman A Rovira J de Sa AJ Thompson 2000 One year follow up study of primary and transitional progressive multiple sclerosis J Neurol Neurosurg Psychiatry 6 713 718 10.1136/jnnp.68.6.713 (Pubitemid 30265270)
15. E Pagani MA Rocca A Gallo M Rovaris V Martinelli G Comi M Filippi 2005 Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype Am J Neuroradiol 26 341 346 15709132
16. J Sharma MP Sanfilipo RH Benedict B Weinstock-Guttman FE Munschauer 3rd R Bakshi 2004 Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation Am J Neuroradiol 25 985 996 15205136
17. H Butzkueven SC Kolbe DJ Jolley JY Brown MJ Cook IA van der Mei PS Groom J Carey J Eckholdt JP Rubio BV Taylor PJ Mitchell GF Egan TJ Kilpatrick 2008 Validation of linear cerebral atrophy markers in multiple sclerosis J Clin Neurosci 15 130 137 10.1016/j.jocn.2007.02.089 1:STN:280:DC%2BD2sjmslOjtg%3D%3D 18068987
18. JF Kurtzke 1983 Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1444 1452 1:STN:280:DyaL2c%2FktValsQ%3D%3D 6685237
19. RH Roxburgh SR Seaman T Masterman AE Hensiek SJ Sawcer S Vukusic I Achiti C Confavreux M Coustans E le Page G Edan GV McDonnell S Hawkins M Trojano M Liquiri E Cocco MG Marruso F Tesser MA Leone A Weber F Zipp B Miterski JT Epplen A Oturai PS Sørensen EG Celius NT Lara X Montalban P Villoslada AM Silva M Marta I Leite B Dubois J Rubio H Butzkueven T Kilpatrick MP Mycko KW Selmaj ME Rio M Sá G Salemi G Savettieri J Hillert DA Compston 2005 Multiple sclerosis severity score: using disability and disease duration to rate disease severity Neurology 64 1144 1151 1:STN:280:DC%2BD2M7ptFeltw%3D%3D 15824338
20. CM Poser DW Paty L Scheinberg WI McDonald FA Davis GC Ebers KP Johnson WA Sibley DH Silberberg WW Tourtellotte 1983 New diagnostic criteria for multiple sclerosis: guidelines for research protocols Ann Neurol 13 227 231 10.1002/ana.410130302 1:STN:280:DyaL3s3gt1OgtQ%3D%3D 6847134 (Pubitemid 13158528)
21. CH Polman SC Reingold G Edan M Filippi Hartung HP L Kappos FD Lublin LM Metz HF McFarland PW O'Connor M Sandberg-Wollheim AJ Thompson BG Weinshenker JS Wolinsky 2005 Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" Ann Neurol 58 840 846 10.1002/ana.20703 16283615 (Pubitemid 41746873)
22. J Martola L Stawiarz S Fredrikson J Hillert J Bergström O Flodmark M Kristoffersen Wiberg 2007 Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development J Neurol Neurosurg Psychiatry 78 375 380 17119006
23. J Martola L Stawiarz S Fredrikson J Hillert J Bergstrom O Flodmark P Aspelin M Kristoffersen Wiberg 2008 Rate of ventricular enlargement in multiple sclerosis: a nine-year magnetic resonance imaging follow-up study Acta Radiol 49 570 579 10.1080/02841850802039898 1:STN:280:DC%2BD1cvgtVOmtQ%3D%3D 18568545
24. Martola J, Stawiarz L, Fredrikson S, Hillert J, Bergström J, Flodmark O, Aspelin P, Kristoffersen Wiberg M (2009) One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging. Acta Radiol 1-9
25. Armatige P, Berry G, Matthews JNS (2002) Statistical methods in medical research, 4th edn. Blackwell, Oxford, p 496
26. VM Anderson NC Fox DH Miller 2006 Magnetic resonance imaging measures of brain atrophy in multiple sclerosis J Magn Res Imaging 23 605 618 10.1002/jmri.20550
27. J Hobart J Freeman A Thompson 2000 Kurtzke scales revisited: the application of psychometric methods to clinical intuition Brain 123 1027 1040 10.1093/brain/123.5.1027 10775547
28. RI Scahill C Frost R Jenkins JL Whitwell MN Rossor NC Fox 2003 A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging Arch Neurol 60 989 994 10.1001/archneur.60.7.989 12873856 (Pubitemid 36858359)
29. M Bozalli M Cercignani C Caltagirone 2008 Brain volumetrics to investigate aging and the principal forms of degenerative cognitive decline: a brief report Magn Reson Imaging 26 1065 1070 10.1016/j.mri.2008.01.044
30. P Kochunov PM Thompson TR Coyle JL Lancaster V Kochunov D Royall JF Mangin D Rivière PT Fox 2008 Relationship among neuroimaging indices of cerebral health during normal aging Hum Brain Mapp 29 36 45 10.1002/hbm.20369 17290369
31. MA Horsfield M Rovaris MA Rocca P Rossi RH Benedict M Filippi R Bakshi 2003 Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences J Neurol Sci 216 169 177 10.1016/j.jns.2003.07.003 1:STN:280:DC%2BD3srjtVegtw%3D%3D 14607319 (Pubitemid 37371880)
32. PD Molyneux L Kappos C Polman C Pozzilli F Barkhof M Filippi T Yousry D Hahn K Wagner M Ghazi K Beckmann F Dahlke N Losseff GJ Barker AJ Thompson DH Miller 2000 The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive multiple sclerosis Brain 123 2256 2263 10.1093/brain/123.11.2256 11050025